CA Patent

CA2780428C — Tablet formulations of neratinib maleate

Assigned to Wyeth LLC · Expires 2018-02-13 · 8y expired

What this patent protects

The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.

USPTO Abstract

The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.

Drugs covered by this patent

Patent Metadata

Patent number
CA2780428C
Jurisdiction
CA
Classification
—
Expires
2018-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.